The cash flow of BIO-TECHNE Corp over the past 10 years
Chart BIO-TECHNE Corp: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2026 Open the chart →In fiscal 2026, the latest fiscal year on file, BIO-TECHNE Corp's operating cash flow was $292.07M and its capital expenditures $28.85M, leaving free cash flow of $263.22M. Free cash flow was above zero in all 10 years shown. It ranged from $128.54M in fiscal 2017 to $307.86M in fiscal 2021. Capital expenditures were highest in fiscal 2024, at $62.88M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2026ended Jun 30, 2026 | $292.07M | $28.85M | $263.22M |
| 2025ended Jun 30, 2025 | $287.56M | $31.01M | $256.55M |
| 2024ended Jun 30, 2024 | $298.98M | $62.88M | $236.1M |
| 2023ended Jun 30, 2023 | $254.39M | $38.24M | $216.15M |
| 2022ended Jun 30, 2022 | $325.27M | $44.91M | $280.36M |
| 2021ended Jun 30, 2021 | $352.16M | $44.3M | $307.86M |
| 2020ended Jun 30, 2020 | $205.22M | $51.74M | $153.47M |
| 2019ended Jun 30, 2019 | $181.62M | $25.41M | $156.21M |
| 2018ended Jun 30, 2018 | $170.37M | $20.93M | $149.43M |
| 2017ended Jun 30, 2017 | $143.72M | $15.18M | $128.54M |
Fiscal years as BIO-TECHNE Corp reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on BIO-TECHNE Corp
- The revenue of BIO-TECHNE Corp
- The profitability of BIO-TECHNE Corp
- The debt of BIO-TECHNE Corp
- The dividends of BIO-TECHNE Corp
- All of BIO-TECHNE Corp's financials, charted
Companies of a similar size
- WSEWise Group plc
- ELANElanco Animal Health Incorporated
- FNFABRINET
- TIGRUP FINTECH HOLDING LIMITED
- IONQIonQ, Inc.
Not investment advice. This page shows what BIO-TECHNE Corp filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.